Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
HIV Drugs Ease Inflammation in 'Controllers'

Putting HIV controllers -- who ordinarily don't need therapy -- on highly active antiretroviral treatment (HAART) appeared to reduce markers of chronic inflammation, a researcher said here.

Published
04 March 2013
From
MedPage Today HIV/AIDS
Case report of a 'functional' HIV cure in a child

Researchers in the United States say that they have identified a case of a 'functional' HIV cure in a child infected with HIV who began antiretroviral treatment

Published
03 March 2013
By
Keith Alcorn
Prezista (darunavir) label change - drug interaction information

The FDA recently approved changes to the Prezista (darunavir) label to reflect drug interaction information with artemether/lumefantrine. The specific changes are outlined below.

Published
02 March 2013
From
US Food and Drug Administration
Intelence (etravirine) labeling updates

On February 27, 2013, FDA approved changes to the Intelence (etravirine) label to include revisions to the Warnings and Precautions, Adverse Reactions, and Postmarketing Experience sections to include information regarding drug rash with eosinophilia and systemic symptoms (DRESS), to update Adverse Reaction section with information regarding the occurrence of rash in men vs. women and pediatric patients and to add drug interaction information for artemether/lumefantrine and telaprevir

Published
02 March 2013
From
US Food and Drug Administration
Program to Cut HIV Transfer to Babies Gets High Marks

The African nation of Malawi is getting an A+ for its aggressive approach to preventing HIV transmission from mothers to babies.

Published
02 March 2013
From
MedPage Today HIV/AIDS
In resource-rich countries, migrants have a higher risk of progressing to AIDS in the first year of HIV therapy

Rates of AIDS-defining illnesses in the first year of antiretroviral therapy are significantly higher among migrant than non-migrant populations in resource-rich countries, investigators report in the online edition

Published
01 March 2013
By
Michael Carter
Study shows value of hepatitis C therapy for HIV co-infected patients with compensated cirrhosis

Spanish research published in the online edition of Clinical Infectious Diseases shows the benefits of successful hepatitis C therapy for people co-infected with HIV who have compensated liver

Published
28 February 2013
By
Michael Carter
Counseling Helps HIV Patients Stick to Tx

(MedPage Today) -- HIV patients receiving a year-long counseling program on problem solving showed better adherence to drug therapy in a randomized study, researchers said.

Published
27 February 2013
From
MedPage Today HIV/AIDS
Meta-analysis shows superiority of integrase inhibitors in first-line HIV therapy and benefits for people changing treatment due to resistance

Antiretroviral combinations based on an integrase inhibitor are superior to other first-line HIV treatment regimens, according to the results of a meta-analysis published in the open access journal

Published
26 February 2013
By
Michael Carter
When to Start ART in Africa — An Urgent Research Priority

We believe that a randomized, controlled trial should be undertaken immediately to determine when to initiate ART in Africa for maximal individual health benefit. It is feasible to conduct a large, simple trial to assess the risks and benefits of immediate ART versus deferral until a CD4+ count of 350 cells per cubic millimeter is reached.

Published
23 February 2013
From
New England Journal of Medicine

Filter by country